BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35728013)

  • 21. The effect of HAART and calendar period on Kaposi's sarcoma and non-Hodgkin lymphoma: results of a match between an AIDS and cancer registry.
    Pipkin S; Scheer S; Okeigwe I; Schwarcz S; Harris DH; Hessol NA
    AIDS; 2011 Feb; 25(4):463-71. PubMed ID: 21139489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The presentation and survival of patients with non-cutaneous AIDS-associated Kaposi's sarcoma.
    Stebbing J; Mazhar D; Lewis R; Palmieri C; Hatzimichael E; Nelson M; Gazzard B; Bower M
    Ann Oncol; 2006 Mar; 17(3):503-6. PubMed ID: 16311274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients. CISIH 92. Centre d'information et de soins de l'immunodéficience humaine.
    Dupont C; Vasseur E; Beauchet A; Aegerter P; Berthé H; de Truchis P; Zucman D; Rouveix E; Saiag P
    AIDS; 2000 May; 14(8):987-93. PubMed ID: 10853980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kaposi's sarcoma in patients with human immunodeficiency virus infection in Taiwan.
    Lin CY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Lo YC; Hung CC; Chang SC
    J Microbiol Immunol Infect; 2009 Jun; 42(3):227-33. PubMed ID: 19812856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AIDS-related Kaposi's sarcoma: state of the art and therapeutic strategies.
    Martellotta F; Berretta M; Vaccher E; Schioppa O; Zanet E; Tirelli U
    Curr HIV Res; 2009 Nov; 7(6):634-8. PubMed ID: 19929800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy.
    Uldrick TS; Wyvill KM; Kumar P; O'Mahony D; Bernstein W; Aleman K; Polizzotto MN; Steinberg SM; Pittaluga S; Marshall V; Whitby D; Little RF; Yarchoan R
    J Clin Oncol; 2012 May; 30(13):1476-83. PubMed ID: 22430271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regression of acquired immunodeficiency syndrome-related pulmonary Kaposi's sarcoma after highly active antiretroviral therapy.
    Aboulafia DM
    Mayo Clin Proc; 1998 May; 73(5):439-43. PubMed ID: 9581584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential drug interaction with paclitaxel and highly active antiretroviral therapy in two patients with AIDS-associated Kaposi sarcoma.
    Bundow D; Aboulafia DM
    Am J Clin Oncol; 2004 Feb; 27(1):81-4. PubMed ID: 14758138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Change in Pattern of Secondary Cancers After Kaposi Sarcoma in the Era of Antiretroviral Therapy.
    Mukhtar F; Ilozumba M; Utuama O; Cimenler O
    JAMA Oncol; 2018 Jan; 4(1):48-53. PubMed ID: 28837714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AIDS-associated Kaposi sarcoma: outcomes after initiation of antiretroviral therapy at a university-affiliated hospital in urban Zimbabwe.
    Nelson BC; Borok MZ; Mhlanga TO; Makadzange AT; Campbell TB
    Int J Infect Dis; 2013 Oct; 17(10):e902-6. PubMed ID: 23809198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy.
    Martinez V; Caumes E; Gambotti L; Ittah H; Morini JP; Deleuze J; Gorin I; Katlama C; Bricaire F; Dupin N
    Br J Cancer; 2006 Apr; 94(7):1000-6. PubMed ID: 16570046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
    Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
    Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of protease inhibitor-based highly active antiretroviral therapy on survival in HIV-associated advanced Kaposi's sarcoma patients treated with chemotherapy.
    Leitch H; Trudeau M; Routy JP
    HIV Clin Trials; 2003; 4(2):107-14. PubMed ID: 12671778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The interaction between smoking status and highly active antiretroviral therapy (HAART) use on the risk of Kaposi's sarcoma (KS) in a cohort of HIV-infected men.
    Luu HN; Amirian ES; Scheurer ME
    Br J Cancer; 2013 Mar; 108(5):1173-7. PubMed ID: 23422755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prognostic index for AIDS-associated Kaposi's sarcoma in the era of highly active antiretroviral therapy.
    Stebbing J; Sanitt A; Nelson M; Powles T; Gazzard B; Bower M
    Lancet; 2006 May; 367(9521):1495-502. PubMed ID: 16679162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy.
    Cattelan AM; Calabrò ML; De Rossi A; Aversa SM; Barbierato M; Trevenzoli M; Gasperini P; Zanchetta M; Cadrobbi P; Monfardini S; Chieco-Bianchi L
    Int J Oncol; 2005 Sep; 27(3):779-85. PubMed ID: 16077928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fatal Disseminated Kaposi's Sarcoma in Two Patients with Human Immunodeficiency Virus (HIV) Infection.
    Fardin RB; Leite LAC; Bezerra LMDS; Alves PMP; Dos Santos LL; Salvá MA; Rezende Filho ALSM; Lima GS; Matos JA; Ferreira SMS; Costa DLJF
    Am J Case Rep; 2018 Jul; 19():868-874. PubMed ID: 30042376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paediatric intussusception caused by acquired immunodeficiency syndrome-associated Kaposi sarcoma.
    Ramdial PK; Sing Y; Hadley GP; Chotey NA; Mahlakwane MS; Singh B
    Pediatr Surg Int; 2010 Aug; 26(8):783-7. PubMed ID: 20535484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Case of Ocular Kaposi's Sarcoma Successfully Treated with Highly Active Antiretroviral Therapy (HAART) Combined with Docetaxel.
    Jin C; Minhas H; Kaur A; Kodali S; Gotlieb V
    Am J Case Rep; 2018 Sep; 19():1074-1077. PubMed ID: 30197412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.